Polycystic ovarian syndrome (PCOS) is a heterogeneous endocrine disorder with the
underline indication of ovarian cysts, anovulation, and endocrine variation affecting the …

Abstract Tamoxifen (ICI 46 474), trans-1-(4-β-dimethylaminoethoxyphenyl)-1, 2-diphenylbut-
1-ene, is the most commonly used drug for the treatment of estrogen receptor positive breast …

The treatment of infertile women with polycystic ovary syndrome (PCOS) is surrounded by
many controversies. This paper describes, on the basis of the currently available evidence …

Nuclear receptors are ligand-activated transcription factors and include the receptors for
steroid hormones, lipophilic vitamins, sterols, and bile acids. These receptors serve as …

Breast cancer is a heterogeneous disease affecting thousands of people every year.
Multiple factors are responsible in causing breast cancer while a number of treatment …

The objective of this narrative review was to suggest a rational order of treatment choices in
anovulatory women with polycystic ovary syndrome (PCOS), for whom a multitude of …

Abstract Hoffman, JR, Kraemer, WJ, Bhasin, S, Storer, T, Ratamess, NA, Haff, GG,
Willoughby, DS, and Rogol, AD. Position stand on Androgen and human growth hormone …

BACKGROUND The effects of controlled ovarian hyperstimulation (COH) for IVF in terms of
breast cancer risk remain controversial, despite the hormone-dependent nature of the latter …

Uncertainty continues as to whether treatments for ovulation induction are associated with
increased risk of cancer. The authors conducted a long-term population-based historical …

Tamoxifen is an anti‐estrogen drug widely used for the treatment of hormone‐sensitive
breast cancer. Approximately 43% of breast cancer patients treated with tamoxifen develop …